Evidence map›Paper›PMID 37217598›Full record

ArticleScientific reports2023

Solid acid-catalyzed one-step synthesis of oleacein from oleuropein.

Yasuhiro Shimamoto, Tadahiro Fujitani, Eriko Uchiage, Hiroko Isoda, Ken-Ichi Tominaga

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yasuhiro ShimamotoNational Institute of Advanced Industrial Science and Technology (AIST), Interdisciplinary Research Center of Catalytic Chemistry, Central 5, 1-1-1 Higashi, Tsukuba, Ibaraki, 305-8565, Japan.
Tadahiro FujitaniNational Institute of Advanced Industrial Science and Technology (AIST), Interdisciplinary Research Center of Catalytic Chemistry, Central 5, 1-1-1 Higashi, Tsukuba, Ibaraki, 305-8565, Japan.
Eriko UchiageNational Institute of Advanced Industrial Science and Technology (AIST), Open Innovation Laboratory for Food and Medicinal Resource Engineering, 1-1-1 Tennodai, Tsukuba, 305-8577, Japan.
Hiroko IsodaNational Institute of Advanced Industrial Science and Technology (AIST), Open Innovation Laboratory for Food and Medicinal Resource Engineering, 1-1-1 Tennodai, Tsukuba, 305-8577, Japan.
Ken-Ichi TominagaNational Institute of Advanced Industrial Science and Technology (AIST), Interdisciplinary Research Center of Catalytic Chemistry, Central 5, 1-1-1 Higashi, Tsukuba, Ibaraki, 305-8565, Japan. k-tominaga@aist.go.jp.
National Institute of Advanced Industrial Science and Technology · JPUniversity of Tsukuba · JP

Funding

JST COI-NEXT JPMJPF2017JST SATREPS JPMJSA1506
6 · The paper itself

Abstract

In this study, we developed a new synthetic strategy to convert secoiridoid glucosides into unique dialdehydic compounds using solid acid catalysts. Specifically, we succeeded in the direct synthesis of oleacein, a rare component of extra-virgin olive oil, from oleuropein, which is abundant in olive leaves. Whereas the conventional total synthesis of oleacein from lyxose requires more than 10 steps, these solid acid catalysts enabled the one-step synthesis of oleacein from oleuropein. A key step in this synthesis was the selective hydrolysis of methyl ester. Density functional theory calculations at the B3LYP/631+G (d) level of theory revealed the formation of a tetrahedral intermediate bonded to one H

Identifiers

PMID37217598
PMCPMC10203140
OpenAlexW4377287677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.